Heidi Overton, President Donald Trump’s nominee to lead the Food and Drug Administration, declined to give clear answers on some of the most politically charged issues facing the agency, including vaccines, birth control and vaping products. The hearing underscored how the FDA’s next leader could be forced to navigate a collision between public health science, consumer access and the administration’s broader ideological agenda.
🌐 Global Edition • Big Tech, Cloud & SemiconductorsRDU GLOBAL CORRESPONDENT
VERIFIED WIRE INTELLIGENCE
"Trump FDA Pick Dodges Key Questions on Vaccines, Birth Control and Vapes"
Heidi Overton, President Donald Trump’s nominee to lead the Food and Drug Administration, declined to give clear answers on some of the most politically charged issues facing the agency, including vaccines, birth control and vaping products. The hearing underscored how the FDA’s next leader could be forced to navigate a collision between public health science, consumer access and the administration’s broader ideological agenda.
Trump FDA Pick Dodges Key Questions on Vaccines, Birth Control and Vapes
R
RDU Global Wire
Big Tech, Cloud & Semiconductors Desk
Washington, D.C., United States Just now (09:43 PM IST)•5 min read
Heidi Overton, President Donald Trump’s nominee to lead the Food and Drug Administration, declined to give clear answers on some of the most politically charged issues facing the agency, including vaccines, birth control and vaping products. The hearing underscored how the FDA’s next leader could be forced to navigate a collision between public health science, consumer access and the administration’s broader ideological agenda.
Editorial & Verification Notice
Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.
Related Coverage
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTHegseth’s Low-Testosterone Screening Plan Could Flag Up to a Quarter of the Army, Raising Medical and Readiness Concerns
A proposed low-testosterone screening initiative associated with Defense Secretary Pete Hegseth is drawing scrutiny from medical experts and military observers after estimates suggested it could identify as many as 25 percent of Army personnel. Clinicians say blanket screening is not supported by evidence and could produce false positives, unnecessary treatment, and avoidable disruption across the force.
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTGoogle’s Android Laptop Push Shows the Platform Still Has a Long Way to Go
Google’s latest attempt to bring Android to laptops underscores both the ambition and the limits of the company’s cross-device strategy. While the idea of a familiar mobile operating system on larger screens is appealing, the early reality suggests Android laptops still feel more like Android than a true desktop alternative.
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTRFK Jr. Reportedly Urges FDA to Tolerate Unproven Peptides, Raising Safety and Oversight Concerns
Robert F. Kennedy Jr. has reportedly proposed that the Food and Drug Administration take a lighter-touch approach toward unproven peptide products, according to a new report. The move comes as FDA scientists say none of the popular peptide drugs have been proven safe or effective, intensifying debate over consumer protection, medical evidence, and regulatory authority.